Loading...
Gaucher disease and the clinical experience with substrate reduction therapy.
Gaucher disease is caused by an enzymatic defect with consequent accumulation of glucocerebroside. Type I, the non-neuronopathic form, is rather common and panethnic. Patients may present with hepatosplenomegaly, anaemia, thrombocytopenia and skeletal or lung involvement. Enzyme replacement therapy...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2003
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1693183/ https://ncbi.nlm.nih.gov/pubmed/12803930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rstb.2003.1272 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|